The utility of value frameworks in cost communications: making them real for patients-Reference-Cited by-同舟云学术

The utility of value frameworks in cost communications: making them real for patients

Published:2024-07-14 Issue:9 Volume:116 Page:1411-1413
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Shih Ya-Chen Tina¹^ORCID,Yabroff K Robin²,Bradley Cathy³^ORCID

Affiliation:

1. University of California Los Angeles Jonsson Comprehensive Cancer Center and Department of Radiation Oncology, School of Medicine , Los Angeles, CA, USA

2. Department of Surveillance and Health Equity Science, American Cancer Society , Atlanta, GA, USA

3. University of Colorado Comprehensive Cancer Center and Department of Health Systems, Management & Policy, Colorado School of Public Health , Aurora, CO, USA

Funder

National Cancer Institute

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/jnci/advance-article-pdf/doi/10.1093/jnci/djae156/58537735/djae156.pdf

Reference16 articles.

1. NCCN Evidence Blocks;Carlson;J Natl Compr Canc Netw,2016

2. Updating the American Society of Clinical Oncology value framework: revisions and reflections in response to comments received;Schnipper;J Clin Oncol,2016

3. A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS);Cherny;Ann Oncol,2015

4. Trends in the cost and use of targeted cancer therapies for the privately insured nonelderly: 2001 to 2011;Shih;J Clin Oncol,2015

5. Rising prices of targeted oral anticancer medications and associated financial burden on Medicare beneficiaries;Shih;J Clin Oncol,2017